Gökbuget, N., Stelljes, M., Fiedler, W., Panse, J., Viardot, A., Heberling, L., Jung, W., Faul, C., Hanoun, M., Nachtkamp, K., Krauter, J., Hindahl, H., Renzelmann, A., Buecklein, V., Schwartz, S., Reiser, L., Brüggemann, M., Oellerich, T., Serve, H., Steffen, B. (2025). Outcome of adult B-precursor acute lymphoblastic leukemia (ALL) treated with blinatumomab in addition to chemotherapy independent of MRD: First results from the national GMALL registry. Blood. https://doi.org/10.1182/blood-2025-5124